Triochem Products Ltd. — Earnings Release 2026

Aug 14, 2025

TRIOCIIEM PRODUCTS IIMITED

Registered Office: 4th Floor, Sambava Chambers, Sir. P. M Road, Forty Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 5150 Fax: 00 91 (22) 2282 8181 E-mall: info@ amDhrav.com Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544

Ref No: TPL PP 20250647 2025; 14th August 2025

To BSE Limited Coaporate Relationship Department, Phiroze ]eejeebhoy Towers, Dalal Street, Fort, Mumbai: 400 001. _Security Code No. 512101 -ISIN No.: INE331E01015.

Dear Sir / Madam,

Sub: Outcome of the Board Meeting held on Thursday 14th August 2025 Ref: Regulation 30 and 33 of the SEBI (|dstlng Obligations and Disclosues Requirements) Regrilatiop, 2015

We would hike to inform you that, pursuant to Notice of Board meeting dated 6th August 2025 the Board Meeting of the Company was held today Thursday 14th August 2025 at 3.00 p.in. at 4th Floor, Sambava Chambers, Sir P. M. Road, Fort, Mumbai: 400001, the registered office of the Company, In pursuant to Regulation 30 and Regulation 53 of the SEBI qisting Obligations and Disclosure Requirements) Regulation, 2015, the Board has considered an approved the following matters amongst other:

1. The Board approved the Unaudited Standalone Financial Results for the quarter ended on 30th June 2025, as reviewed by the Audit Committee, in accordance with Regulation 33 of SEBI qisting Obrigatious and Disclosure Requirements) Regulation, 2015.

The Company has temporarily reduced activity due to the impact of Covid-19 pandemic. The business that requires personal presentation & relationship bu4ding has taken a tremendous hit & is unlikely to see any possibhity of revival in the immediate future, business from the regular customers is shrink. We do not see significant improvement, therefore temporarily reduced activities till a clearer picture emerges.

The Company has sufficient liquidity to meet its financial obligations, we are also making regular payments to our suppliers, employees, and other people concerned. The liquidity position of the company is in comfortable zone.

After Careful consideration and review of Unaudited Standalone Financial Results for the quarter ended on 30th June 2025 were approved by the Board.

1. The Board noted and took on records the Limited Review Report for the quarter ended on 50th]une 2025 as placed before the Board.

i TRIOCHEM PRODUCTS LIMITED

Registered Offroe: 4th Floor, Sambawa Chambers, Sir. P. M. Road, Forty Mumbal, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2282 8181 E-mall: info@amDhrav. com Website: www.triochemoroducts.com Corporate Identity Number: L24249MH1972PLC015544

i

• 1. The Board discussed and took note of the statement of deviation or variation in public issue, rights issue, preferential issue, etc. under Regulation 32(1) of SEBI qisting Obligations and Disclosure Requirements) Regulations, 2015 for the Quarter ended 30th June 2025 as amended as per Circular No. CIR/CFD/CMD1/162/2019, dated 24th December 2019, duly reviewed by the Audit Committee along and the auditor's comments, that, The statement of Category wise variation is also not applicable as there has been no offer made by way of Public Issue, Rights Issue, Preferential Issue, etc., during the Quarter ended 30th June 2025.
• 1. Take notes on the compliance for the quarter ended 30thJune 2025. The Board of Directors observed that, the Company is in compliance with the applicable provisions of the securities laws.
• 1. Board Meeting commenced at 3.00 p.in. and concluded at 3.50 p.in.

You are requested to take note of the sane. Thankingyou, Yours faithfully, For TRIOCHEM PRODUCTS LIMITED

RAMU S. DEORA DIRECTOR DIN: 00312369 Place: Mumbai RAMU SITARAM DEORA Digitally signed by RAMU SITARAM DEORA Date: 2025.08.14 15:34:42 +05'30'

Kanu Doshi Associates LLP

Chartered Accountants

Independent Auditor's Review Report on Unaudited Quarterly Financial Results of the Company Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended)

To.

The Board of Directors of TRIOCHEM PRODUCTS LIMITED (" The company")

• 1. We have reviewed the accompanying statement of unaudited financial results of TRIOCHEM PRODUCTS LIMITED ("The company") for the quarter ended June 30, 2025 being submitted by the Company pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended), including relevant circulars issued by SEBI from time to time.
• 1. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (Ind AS 34) "Interim Financial Reporting" prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review.
• 1. We conducted our review of the statement in accordance with the Standard on Review Engagement (SRE) 2410, 'Review of Interim Financial Information performed by Independent Auditor of the Entity' issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. Our review is limited primarily to inquiries of company personnel and an analytical procedure applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion.
• 1. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian Accounting Standards (Ind AS) and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 including the manner in which it is to be disclosed, or that it contains any material misstatement.

For Kanu Doshi Associates LLP Chartered Accountants Firm Registration No: 104746W/W100096

Kunal Vakharia Partner Membership No.: 148916 UDIN: 25148916BMKNOR5896 Place: Mumbai Date: 14th August, 2025

Mumbai Office : 203. The Summit. Hanuman Road, Western Express Highway, Vile Parle (E), Mumbai - 400 057 T : 022-2615 0100 Pune Office: 109. Sohrab Hall, 21 Sassoon Road, Opp. Jehangir Hospital, Pune - 411001 T: 020-4906 7177 E info@kdg.co.in W www.kdg.co.in FRN: 104746W/W100096

TRIOCHEM PRODUCTS LIMITED

Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2282 8181. E-mall: info@amphray.com; Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544.

roducts rm₁ mbai

TRIOCHEM PRODUCTS LIMITED

Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2282 8181. E-mall: info@amphray.com; Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544.

$\mathcal{L}$

TRIOCHEM PRODUCTS LIMITED

Registered Office: 4^th Floor, Sambava Chambers, Sir. P. M. Road, Fort, Mumbai, Maharashtra, PIN: 400001. Telephone: 00 91 (22) 2266 3150 Fax: 00 91 (22) 2282 8181. E-mall: info@amphray.com; Website: www.triochemproducts.com Corporate Identity Number: L24249MH1972PLC015544.

TRIOCHEM PRODUCTS LIMITED Registered Office: Sambaya Chambers, 4th Floor, Sir P. M. Road, Fort, Mumbai - 400 001 website: www.triochemproducts.com CIN: L24249MH1972PLC015544

	(Rs. in lakhs) Except EPS
EXTRACT OF STATEMENT OF UNAUDITED FINANCIAL RESULTS FOR THE QUARTER ENDED 30TH JUNE 2025
Sr	Particulars	For the Quarter Ended			Year Ended
		30-Jun-25	31-Mar-25	30-Jun-24	31-Mar-25
		(Unaudited)	(Audited)	(Unaudited)	(Audited)
	Total Income from operations	22.10	32.47	22.97	105.01
	2 Net Profit / (Loss) for the period (before Tax, Exceptional and / or Extraordinary items)	(15.24)	(2.82)	(9.62)	(24.62)
	3 Net Profit / (Loss) for the period before tax (after Exceptional and / or Extraordinary items)	(15.24)	(2.82)	(9.62)	(24.62)
	$4$ Net Profit / (Loss) for the period after tax (after Exceptional and / or Extraordinary items)	(3.06)	(45.18)	(7.84)	(40.01)
	5 Total Comprehensive Income for the period [Comprising Profit / (Loss)] for the period (after tax) and other Comprehensive Income (after tax)]	89.27	(45.67)	92.13	(55.33)
	6 Equity share capital (Face value Rs.10/- per share)	24.50	24.50	24.50	24.50
	7 Other Equity				1,342.19
	8 Earnings per share (of Rs.10/- each) (for continuing and discontinued operations)
	a) Basic (not annualized)	(1.25)	(18.44)	(3.20)	(16.33)
	b) Diluted (not annualized)	(1.25)	(18.44)	(3.20)	(16.33)
Notes.

1) The above unaudited financial results of the Company for the quarter ended 30th June 2025 have been reviewed by the Audit committee of the Board and approved by the Board of Directors at its meeting held on 14.08.2025. The same have been reviewed by the Statutory Auditors who have issued an unqualified conclusion thereon.

2) The audited financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard (Ind AS) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other accounting principles generally accepted in India., as applicable and guidelines issued by the Securities and Exchange Board of India (SEBI).

3) The Company operates in single segment only, i.e. chemical and pharmaceuticals; therefore, disclosure requirement of Indian Accounting Standard (Ind AS-108) "Segment Reporting" is not applicable.

4) The figures for the preceding quarter ended 31st March, 2025 as reported in these financial results, are the balancing figures between audited figures in respect of the full financial year ended 31st March, 2025 and published year to date unaudited figures upto the end of thrd quater of that financial year.

The Corresponding figures of the previous quarter/year have been regrouped, recasted and reclassified to make them $5)$ comparable wherever necessary.

The above is an extract of the detailed format of financial results filed with the Stock Exchange under Regulation 33 of the SEBI (Listing and Other Disclosure Requirements) Regulation, 2015. The full format of consolidated financial results are available on the Stock Exchange website, www.bseindia.com and on the Company's website www.triochemproducts.com

Place: Mumbai Dated: 14th August, 2025

RAMU S. DEORA CHAIRPERSON DIN: 00312369

FOR TRIOCHEM PRODUCTS LIMITED

6